Evidence map›Paper›PMID 41131219›Full record

ReviewFolia microbiologica2026

Therapeutic advances in the fight against microbial resistance: innovative strategies and future challenges.

Jonathan Mandú de Araújo, Alícia Natalie Silva Dos Santos, Bruno José da Silva Bezerra, Vitória Camilo de Souza Silva, Wênio Sandoval Filho Lima da Silva, Amanda Vieira de Barros, Pablo Antonio Maia de Farias, Henrique Douglas Melo Coutinho, Maria Betânia de Melo Oliveira

Abstract readReview
PubMed Publisher
In one paragraph

Review in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jonathan Mandú de AraújoDepartment of Biochemistry, Biosciences Center, Federal University of Pernambuco, Recife, Brazil.
Alícia Natalie Silva Dos SantosDepartment of Biochemistry, Biosciences Center, Federal University of Pernambuco, Recife, Brazil.
Bruno José da Silva BezerraDepartment of Biochemistry, Biosciences Center, Federal University of Pernambuco, Recife, Brazil.
Vitória Camilo de Souza SilvaDepartment of Biochemistry, Biosciences Center, Federal University of Pernambuco, Recife, Brazil.
Wênio Sandoval Filho Lima da SilvaDepartment of Biochemistry, Biosciences Center, Federal University of Pernambuco, Recife, Brazil.
Amanda Vieira de BarrosDepartment of Biochemistry, Biosciences Center, Federal University of Pernambuco, Recife, Brazil.
Pablo Antonio Maia de FariasCECAPE College, Av. Padre Cícero, 3917 - São José, Juazeiro do Norte, 63024-015, CE, Brazil.
Henrique Douglas Melo CoutinhoDepartment of Biological Chemistry, Regional University of Cariri - URCA, Crato, 63105-000, CE, Brazil. hdmcoutinho@gmail.com.ORCID http://orcid.org/0000-0002-6634-4207
Maria Betânia de Melo OliveiraDepartment of Biochemistry, Biosciences Center, Federal University of Pernambuco, Recife, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial Resistance (AMR) is characterized by the reduced effectiveness of antibiotics due to the adaptation of microorganisms, which limits therapeutic options and increases the severity of infections. This paper aims to discuss therapeutic advances in combating AMR, highlighting innovative strategies, future challenges, and the importance of raising public awareness about the responsible use of antibiotics. This narrative review is based on studies from databases such as the National Library of Medicine, Cumulative Index to Nursing and Allied Health Literature, Web of Science, Scopus, and the Virtual Health Library, using targeted descriptors. The findings emphasize the historical shift from the pre-antibiotic era, marked by high mortality rates, to the antibiotic era, now confronted by the escalating challenge of resistance. Notable innovative strategies include the use of light-based therapies and photosensitizing agents to eradicate bacteria, the application of antimicrobial gases such as nitric oxide and ozone to reduce bacterial loads, and the development of bioactive molecules and cutting-edge technologies aimed at directly targeting resistant pathogens. Advancing these novel therapies, along with raising public awareness about the responsible use of antibiotics, is crucial to curbing the threat of AMR and safeguarding global health.

Indexed as

Anti-Bacterial AgentsBacteriaBacterial InfectionsDrug Resistance, BacterialDrug Resistance, MicrobialHumansAnti-Bacterial AgentsInnovative therapiesPublic healthResistanceResistance mechanisms

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.